Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for advanced or refractory malignancies
NCT00081757Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Sep 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of thalidomide in advanced cancer, sponsored by University of Arkansas. Primary endpoint: Use of thalidomide to treat patients. Started Sep 1998; status: completed.
02
Drugs
thalidomide
03
Conditions
advanced cancer
Beyond the preview
Go deeper on NCT00081757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081757.